Novartis AG (NYSE:NVS) registered a 0.42% increase, still its new closing price is 7.89% up from the company’s 1 year high of 83.58.It posted 2.21% gains in previous 5 sessions and is now the subject of 2 analysts who together assign a hold rating on stock. 0 of Wall Street analysts have an underperform rating; the 0 sells versus 2 buy or better ratings. The 5 stock analysts following this company have an average price target at $91.20, with individual PT in the $80.00-$115.00 range. The shares moved at $72.21, implying that brokerage firms see shares losing about -1.98% in twelve months time.
Novartis AG (NVS) SEC Form 4 News
The stock is getting much attention these days as insiders are adding shares while they posted a -0.86% fall year to date. A 10% Owner at Novartis AG (NVS) acquired shares in a transaction closed on Monday September 22, 2014. Novartis Bioventures Ltd bought 5,700 shares in the company at $15 each and collected $4,875,000 in proceeds. Novartis Bioventures Ltd now owns 325,000 shares in the company after this transaction.
Novartis AG (NYSE:NVS) Upcoming Results on Tap
Novartis AG will next provide financial results for the March 2017 quarter. Stock analysts expect it to report per-share earnings of $1.17 in that period. Sales during the quarter are predicted to arrive at $11.79 billion.
Earnings surprise history: Last quarter, the company posted approximately $12.32 billion in revenue and EPS of $1.11. The mean forecast was for $12.32 billion and $1.11 a share, respectively. One quarter earlier, revenue for the stock was at $12.13 billion, with earnings at $1.23/share.
Novartis AG (NVS) Brokerage Update
Novartis AG (NVS) is in Credit Suisse’s research list so their analyst rating change is noteworthy. These shares were downgraded to Neutral from Outperform by Credit Suisse, according to news reported on Wednesday January 11, 2017.Another important research note was issued by Argus on Thursday November 10, 2016.The firm upgraded NVS to Buy from Hold. Over the last six months and over the last three months, the shares of Novartis AG (NVS), have changed -12.02% and 1.52%, respectively.